Documents Ledipasvir-Sofosbuvir +/- 3 rd DAA in HCV Genotype 1 SYNERGY

PowerPoint Presentation Ledipasvir-Sofosbuvir +/- 3rd DAA in HCV Genotype 1 NIAID SYNERGY: Genotype 1 Phase 2 Treatment Naïve (unfavorable baseline treatment characteristics)…